@bubu12
 

bubu12 : ah parce que actuellement on vaccine en masse les enfants contre le covid peut être ?

"We have already licensed for kids 16 and above... we are already doing trials for kids between 11 years old all the way to 16, and I hope that we will be able to have data in a couple of months. We are also planning to initiate pediatric studies from a younger age, from age 5 all the way to 11. And I believe we should have data about this population by the end of the year," Bourla said, according to NBC.

Pfizer CEO Albert Bourla calls Israel ’world’s lab’ in interview to NBC